• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 491 results

5 Power of Attorney: Power of Attorney

Document IPR2017-01095, No. 5 Power of Attorney - Power of Attorney (P.T.A.B. Apr. 5, 2017)

cite Cite Document
Analyze

6 Mandatory Notice: Mandatory Notice

Document IPR2017-01095, No. 6 Mandatory Notice - Mandatory Notice (P.T.A.B. Apr. 5, 2017)

cite Cite Document
Analyze

4 Notice: Petitioners Updated Mandatory Notice re Lead Backup Counsel

Document IPR2017-01095, No. 4 Notice - Petitioners Updated Mandatory Notice re Lead Backup Counsel (P.T.A.B. Mar. 17, 2017)

cite Cite Document
Analyze

1 Power of Attorney: Petitioners Power of Attorney

Document IPR2017-01095, No. 1 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. Mar. 15, 2017)

cite Cite Document
Analyze

1318 Exhibit: General Information on the EDGAR Database page from Internet Arc...

Document IPR2017-01095, No. 1318-132 Exhibit - General Information on the EDGAR Database page from Internet Archive (P.T.A.B. Jul. 5, 2018)

cite Cite Document
Analyze

2015 Exhibit: EX 2015 Rituxan Label

Document IPR2017-01095, No. 2015-96 Exhibit - EX 2015 Rituxan Label (P.T.A.B. Feb. 7, 2018)

cite Cite Document
Analyze

COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINIST...

Docket 13/524,896, U.S. Patent Application (June 15, 2012)

cite Cite Docket
Analyze

1056 Exhibit: Attachment 2 IDEC Pharmaceuticals Filing Details on the EDGAR sys...

Document IPR2017-01095, No. 1056-48 Exhibit - Attachment 2 IDEC Pharmaceuticals Filing Details on the EDGAR system, available at httpswwwsecgovArchivesedgardata8750450000936392 98 000361...

cite Cite Document
Analyze

1074 Exhibit: E1496 Forms Packet

Document IPR2017-01095, No. 1074-61 Exhibit - E1496 Forms Packet (P.T.A.B. Mar. 15, 2017)

cite Cite Document
Analyze

JTUA3WIJRXEAPX5

Document COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES, 13/524,896, No. JTUA3WIJRXEAPX5 (U.S. Pat. App. Mar. 26, 2019)

cite Cite Document
Analyze

JPMZD0TNRXEAPX2

Document COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES, 13/524,896, No. JPMZD0TNRXEAPX2 (U.S. Pat. App. Nov. 30, 2018)

cite Cite Document
Analyze

JX08TZ32RXEAPX0

Document COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES, 13/524,896, No. JX08TZ32RXEAPX0 (U.S. Pat. App. Jun. 17, 2019)

cite Cite Document
Analyze

JOHW46W7RXEAPX1

Document COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES, 13/524,896, No. JOHW46W7RXEAPX1 (U.S. Pat. App. Nov. 8, 2018)

cite Cite Document
Analyze

JN4I0TPCRXEAPX1

Document COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODIES, 13/524,896, No. JN4I0TPCRXEAPX1 (U.S. Pat. App. Oct. 4, 2018)

cite Cite Document
Analyze

2010 Exhibit: Ex 2010 Prior 172 IPR Board Decision

Document IPR2017-01095, No. 2010-91 Exhibit - Ex 2010 Prior 172 IPR Board Decision (P.T.A.B. Jul. 10, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>